|1.||Ponamarev, Mikhail V: 1 article (05/2003)|
|2.||Longley, Matthew J: 1 article (05/2003)|
|3.||Copeland, William C: 1 article (05/2003)|
|4.||Lim, Susan E: 1 article (05/2003)|
|5.||Goto, T: 1 article (02/2001)|
|6.||Ono, S K: 1 article (02/2001)|
|7.||Carrilho, F J: 1 article (02/2001)|
|8.||Kato, N: 1 article (02/2001)|
|9.||Omata, M: 1 article (02/2001)|
|10.||Shiratori, Y: 1 article (02/2001)|
|1.||Acquired Immunodeficiency Syndrome (AIDS)
10/23/1990 - "Carbovir (CBV) is a highly selective carbocyclic nucleoside inhibitor of HIV replication in human lymphocytes and is potentially useful in the treatment of AIDS [Vince et al. (1988) Biochem. "
02/01/1989 - "Carbovir is a novel carbocyclic nucleoside which has been shown to have potent in vitro activity against human immunodeficiency virus, the causative agent of acquired immunodeficiency syndrome. "
10/31/1988 - "Its hydrolytic stability and its ability to inhibit the infectivity and replication of HIV in T-cells at concentrations of approximately 200- to 400-fold below toxic concentrations make carbovir a top-priority candidate for development as a potential antiretroviral agent in the treatment of AIDS patients."
04/14/1989 - "Carbovir is a novel carbocyclic guanosine derivative that has potent in vitro activity against human immunodeficiency virus, the causative agent of acquired immunodeficiency syndrome (AIDS). "
02/25/1992 - "Carbocyclic 2',3'-didehydro-2',3'-dideoxyguanosine (carbovir, NSC 614846) is an anti-retroviral agent that may be useful in the treatment of AIDS. "
|2.||Chronic Progressive External Ophthalmoplegia (Progressive External Ophthalmoplegia)
|3.||Hepatocellular Carcinoma (Hepatoma)
02/01/2001 - "We investigated the replication fitness and susceptibility of the wild-type and five mutant HBVs (L528M, M552I, M552V, L528M/M552I, and L528M/M552V) to 11 compounds [lamivudine, adefovir, entecavir (BMS-200475) (+)-BCH-189 (+/-)-FTC (racivir) (-)-FTC (emtricitabine) (+)-FTC, L-D4FC, L-FMAU (clevudine), D-DAPD, and (-)-carbovir] by transfecting HBV DNA into hepatoma cells and monitoring viral products by Southern blotting. "
|4.||Body Weight (Weight, Body)
|4.||DNA (Deoxyribonucleic Acid)